Free Sponsored Webinar
Impacting Metabolic Health Through the Gut Microbiome
Join Dr. Adam Perlman, MD, MPH, as he explores the latest research on Akkermansia muciniphila, a pivotal gut microbiome player known for its role in supporting gut barrier integrity and metabolic health. Discover how A. muciniphila, along with novel strains like C. butyricum, can enhance microbiome resilience and optimize metabolic function.
Thursday, January 9, 2025 at 2:00 pm Arizona Time
Disclaimer: Please note that the views and opinions expressed by the speakers or participants during this presentation are those of the speakers or participants and do not necessarily reflect the official policy or position of the Andrew Weil Center for Integrative Medicine. The presentation of this virtual lecture does not imply endorsement of the speaker's or participants' views, products, or services. Viewer discretion is advised.
Speaker:
Adam Perlman, MD, MPH, FACP
Dr. Perlman, Chief Medical Officer at Pendulum Therapeutics, is board-certified in Internal Medicine and specializes in Integrative and Functional Medicine. He leads the medical team at Pendulum Therapeutics, a probiotics company at the forefront of microbiome science with significant backing from Sequoia Capital and the Mayo Clinic. Dr. Perlman previously served as the Director of Integrative Health and Wellbeing for Mayo Clinic. Prior to that, he served as the Associate Vice President for Health and Wellness for the Duke University Health System. Dr. Perlman received his BA from Tufts University, his MD from the Boston University School of Medicine, and his MPH from the Boston University School of Public Health.